The presence of a functional HBV-multispecific CD8+ T-cell response has been correlated with development of HBV control and functional cure after nucleoside analogue treatment discontinuation in HBeAg(−) chronic hepatitis B (6). This evidence concerns the gene CD8A and chronic hepatitis B virus infection.